The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

NCT04212429 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Endophthalmitis Postoperative

Interventions

DRUG: Levofloxacin Ophthalmic Product
DRUG: Moxifloxacin Ophthalmic Solution

Sponsor

National University of Malaysia

Collaborators

[object Object]